[Macrolide-resistant Mycoplasma pneumoniae].

Miyuki Morozumi, Kimiko Ubukata

研究成果: Article

1 引用 (Scopus)

抜粋

Mycoplasma pneumoniae (M. pn) is one of the main pathogens causing community-acquired pneumonia (CAP) in children. In Japan, macrolide (ML)-resistant M. pn was firstly isolated from clinical samples collected from pediatric patients with CAP in 2000, and the agents have rapidly increased. All ML-resistant strains had a point mutation in domain V of the 23S rRNA. Among the patients with ML-resistant M. pn, the duration of fever was significantly longer than in patients with ML-susceptible M. pn infection. The antimicrobial agent was often changed from ML as a first choice agent to minocycline or levofloxacin, because of unimproved clinical symptoms. Further clinical studies are needed to establish appropriate chemotherapy.

元の言語English
ページ(範囲)251-255
ページ数5
ジャーナルNihon rinsho. Japanese journal of clinical medicine
70
発行部数2
出版物ステータスPublished - 2012 2 1

ASJC Scopus subject areas

  • Medicine(all)

フィンガープリント [Macrolide-resistant Mycoplasma pneumoniae].' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用